Greetings TPAC Shareholders,
First, let’s give you a
Greetings TPAC Shareholders,
First, let’s give you a new conscious thought; hold what you know about PPS.
Ready your mind to this...Everyone knows retained earnings/cash-on-hand is the key to a stable stock.
Let’s start with the mindset……. a reverse split isn't going to happen but a buy back may not happen either.
You’re probably saying to yourselves, "this is just crazy".
Here Me Out…
One of the chief reasons TPAC hasn’t taken the $10M loan is because at some point they can use $85M to increase its IPPS.
Remember, TPAC is not the same company of 2014/ 2015; it has drastically changed in 2016.
TPACs moved from manufacturer to service provider with two distinct lines of service.
What does that has to do with the IPPS?
If you take the $85M loan and have nothing else to do with it…it can be placed at the floor….cash-on-hand.
Shareholders were provided this outlook and IPPS formula in the beginning: Retained earnings - Dividends/Outstanding Shares. There are no dividends so let’s run the numbers.
$85M from loan moves to MRVB as cash-on-hand; Retained Earning/Total OS (4B rounded up just for easy calculations) = .021 (this is before any share reduction ). Just based on the loan becoming cash-on-hand, the IPPS value goes sky-high.
The 52 week high is .0072. The loan can automatically propel the stock price pass the 52 week high……
TPAC is looking at things in a different light.
So just with the full loan from EX IM, TPAC could carry out this. Maybe an EIA’s retained earnings in a calendar year can trigger it…note the word “TRIGGER”.
The difference of 90 days ago….the loan was to be used to acquire facilities and increase manufacturing output; today all that has changed through Service Level Agreements and Licensing Agreements. TPAC doesn’t have those prior needs.
TPAC DOESN’T HAVE THE SAME FINANCIAL NEEDS AND IT DOESN’T HAVE DEBT.
TPAC can channel its money elsewhere……. no better place than an MRVB as cash-on-hand. TPAC would never have to do any other business and it would grow just off interest, which is REVENUE.
Add the MRVB and BTL, as long as they are in effect, the IPPS grows AUTOMATICALLY.
TPAC won’t express more information on the teams, just come to know TPAC has an A-TEAM. Their financial backgrounds in WALLSTREET and experiences in GLOBAL MARKETS & MARKETING are bringing a NEW twist to TPAC.
The teams’ goal is to build stability creating self-adjusting self-regenerating systems that allow TPAC to become a prime business in the global landscape.
The company is the key.
Build the company the stock will follow, not the other way around.
This is the best way to raise the IPPS without taking from the Shareholder. These teams are business builders providing CEO Bill McKay with top methodologies that you won’t find in other OTC businesses.
Thanks to CEO Bill McKay, his company framework makes it easier to implement changes at a rapid pace.
If you have any other questions let me know.
No Market Maker can manipulate IPPS
1
1
Trans-Pacific Aerospace (TPAC) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Do Shoppers Believe in Black Friday Anymore? You'd think by now, retailers would have cracked the code on building trust with their customers. But guess what? A fresh survey from Boston Consulting Group reveals only 54% of consumers buy the whole Black Friday discount story. That's barely more than flipping a coin. Promotion Fatigue: The Trust Buster Funny thing,...
Continue Reading
Biotech Giants CStone and Kimia Unite Forces In the heart of China's biotechnology scene, the latest collaboration news to hit the wires is CStone Pharmaceuticals shaking hands with Kimia Therapeutics. Now, don't go tossing this aside as another run-of-the-mill partnership announcement. CStone's HKEX: 2616 ticker has got its eyes locked on an ambitious dance with Kimia,...
Continue Reading
Samsung Biologics Achieves a Low-Risk Triumph You gotta hand it to Samsung Biologics for hitting a 'Negligible Risk' rating. Their latest score? A cool 9.0. That’s like walking into the pharmaceuticals room and getting a standing ovation. It's no small feat—climbing up from a 'Low Risk' rating to the top tier in Morningstar Sustainalytics' playbook. For us spectating...
Continue Reading
Diving into Emergency General Surgery Verification How often do you hear a hospital accreditation making a real difference? The latest report in JAMA Surgery suggests it’s more than just a plaque on the wall for some. We're talking about the American College of Surgeons (ACS) Emergency General Surgery Verification program, which links directly to better patient...
Continue Reading
Stellus Capital's Upcoming Financial Reveal: Stakes and Details November's not just bringing the cold breezes, folks; it's also ushering in the much-anticipated financial digits of Stellus Capital Investment Corporation's third quarter of 2026. Mark your calendars for November 9, after the stock market wraps up, when Stellus will drop its operational performance stats for...
Continue Reading
Unearthing the Hidden Struggle of PAH The American Lung Association (ALA) is getting loud about a quiet killer—pulmonary arterial hypertension (PAH) is in their spotlight this month, and it's about time. Documenting the horror stories of some 500 to 1,000 new PAH diagnoses each year in the U.S., the ALA is peeling back the blinds on a condition that's too often...
Continue Reading
Movie Magic on the Menu When was the last time a bucket of fried chicken sent such ripple effects through pop culture? KFC's decision to sling Doctor Doom-inspired dishes across 100 countries smells like genius business mixed with a dash of the absurd. Just imagine: an empire of battered birds aligning with Marvel's latest cinematic heavy hitter, "Avengers: Doomsday." Now...
Continue Reading
Shaky Ground Beneath AppLovin's Feet Ah, the sweet smell of litigation in the tech space—it’s like déjà vu for seasoned market folks. Here we have AppLovin, nestled comfortably in San Francisco, now eying a saucy class-action lawsuit. We're looking at shareholders taking a firm stance against some arguably misleading claims. We're talking big deals with allegations...
Continue Reading
Breaking Ground in Healthcare Tech Ah, what’s cooking in Singapore? On a day like today, when the tech giants Singtel and Ericsson get chummy with National University Health System (NUHS), we're looking at the kind of healthcare advancements that read like science fiction. They’ve signed an MOU to launch the National University XG AI Centre (NXAC) – a mouthful,...
Continue Reading
Here’s how it is: choosing a lakefront home in Steuben County, Indiana, ain't just about picking a place with a killer view. It’s like buying a lifestyle package and you’d better know what you’re getting. An article by Tony Isa, the go-to real estate guru in these parts, puts the spotlight on Lake James and Clear Lake—but what matters is how each might wrangle...
Continue Reading
Top 5 Most Recently Viewed Articles
Recent Insider Trading at Teva Pharmaceutical Industries A notable insider transaction occurred recently, with Amir Weiss, the Chief Accounting Officer at Teva Pharmaceutical Industries Ltd (NYSE: TEVA), unloading shares worth $300,564 as reported by a recent SEC filing. Details of the Transaction According to the Form 4 filing submitted to the U.S. Securities and...
Continue Reading
Transforming Mobility with Robotaxi Services TIER IV, renowned for developing the first open-source software for autonomous driving, has teamed up with mobility startup Newmo to revolutionize transportation services. This partnership marks a significant step toward the commercialization of robotaxi services, offering solutions tailored for local communities. Your Solution...
Continue Reading
Investors Urged to Take Action After Stock Price Drop Recent developments surrounding Wolfspeed, Inc. have raised significant concerns among investors, especially following the staggering drop in the company's stock price. Those who invested in Wolfspeed, often identified by its ticker WOLF, may now find themselves questioning their portfolio decisions. Amidst this...
Continue Reading
Team Falcons' Incredible Journey to Victory The culmination of the Esports World Cup 2025 showcased an exhilarating journey for Team Falcons, who emerged as the dominant force in this prestigious multi-title esports tournament. Over seven weeks, the tournament attracted a staggering 750 million viewers worldwide and recorded 350 million hours of online watch time. These...
Continue Reading
GENFIT Files 2024 Universal Registration Document Lille, France - GENFIT (Nasdaq and Euronext: GNFT), a pioneering biopharmaceutical firm dedicated to the welfare of patients suffering from rare and life-threatening liver conditions, has achieved a significant milestone by filing its 2024 Universal Registration Document alongside its Annual Report on Form 20-F with...
Continue Reading